These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8188458)

  • 1. [Diabetic Nephropathy. Captopril can improve survival in hypertensive diabetics. Proceedings of a symposium at the IFECC III. Monte Carlo, January 1994].
    Internist (Berl); 1994 Apr; 35(4 Suppl):1-4. PubMed ID: 8188458
    [No Abstract]   [Full Text] [Related]  

  • 2. Captopril in diabetic nephropathy.
    Fong M; Hart LL
    DICP; 1990 Mar; 24(3):260-1. PubMed ID: 2180219
    [No Abstract]   [Full Text] [Related]  

  • 3. Captopril and diabetic nephropathy.
    Lewis EJ
    JAMA; 1995 Jun; 273(23):1831. PubMed ID: 7776492
    [No Abstract]   [Full Text] [Related]  

  • 4. Captopril for diabetic nephropathy.
    Med Lett Drugs Ther; 1994 May; 36(923):46-7. PubMed ID: 8177138
    [No Abstract]   [Full Text] [Related]  

  • 5. Captopril, blood pressure, and diabetic nephropathy.
    Sawicki PT; Mühlhauser I; Berger M
    JAMA; 1994 Oct; 272(13):1005. PubMed ID: 8089882
    [No Abstract]   [Full Text] [Related]  

  • 6. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Romanelli G; Giustina A; Cravarezza P; Caldonazzo A; Agabiti-Rosei E; Giustina G
    J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
    Ratzmann KP; Raskovic M; Schimke E
    Dtsch Med Wochenschr; 1994 Jun; 119(22):796-800. PubMed ID: 8205941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slowing the progression of diabetic nephropathy.
    Remuzzi G; Ruggenenti P
    N Engl J Med; 1993 Nov; 329(20):1496-7. PubMed ID: 8413463
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
    Parving HH; Hommel E; Jensen BR; Hansen HP
    Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
    Fournier A; Lalau JD
    N Engl J Med; 1994 Mar; 330(13):937; author reply 938. PubMed ID: 8114873
    [No Abstract]   [Full Text] [Related]  

  • 11. Changing the course of diabetic nephropathy: angiotensin-converting enzyme inhibition in type I diabetic renal disease.
    Pohl MA
    Cleve Clin J Med; 1994; 61(1):38-42. PubMed ID: 8124846
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
    Parving HH
    N Engl J Med; 1994 Mar; 330(13):937-8. PubMed ID: 8114875
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihypertensives retarding progression of diabetic nephropathy.
    Hardy KJ
    Diabetologia; 1995 Jan; 38(1):123-4. PubMed ID: 7744219
    [No Abstract]   [Full Text] [Related]  

  • 14. [Captopril reduction of albuminuria in type-II diabetics with diabetic nephropathy].
    Melchor-Ortiz JL; Wacher-Rodarte N; Halabe-Cherem J; Lifshitz-Guinzberg A
    Gac Med Mex; 1991; 127(3):261-6. PubMed ID: 1800220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of captopril on heavy proteinuria in azotemic diabetics.
    Taguma Y; Kitamoto Y; Futaki G; Ueda H; Monma H; Ishizaki M; Takahashi H; Sekino H; Sasaki Y
    N Engl J Med; 1985 Dec; 313(26):1617-20. PubMed ID: 3906398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of angiotensin converting enzyme inhibitors in the treatment of diabetic nephropathy].
    Romero R; Sanmartí A; Salinas I; Teixidó J; Foz M; Caralps A
    Med Clin (Barc); 1988 Mar; 90(12):494-6. PubMed ID: 3292854
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
    Lopez A; Marantz PR
    N Engl J Med; 1994 Mar; 330(13):937; author reply 938. PubMed ID: 8114874
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmaclinics. Drug of the month. Captopril (Capoten) in diabetic nephropathies].
    Scheen AJ
    Rev Med Liege; 1995 Oct; 50(10):445-6. PubMed ID: 7491445
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
    Insua A; Ribstein J; Mimran A
    Postgrad Med J; 1988; 64 Suppl 3():59-62; discussion 90-2. PubMed ID: 3074298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between the effect of glibenclamide and captopril on experimentally induced diabetic nephropathy in rats.
    Akbar DH; Hagras MM; Amin HA; Khorshid OA
    J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):103-15. PubMed ID: 23077081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.